Archive by category | Policy

Timeline of events: A brief history of what made news this year

Timeline of events: A brief history of what made news this year

This year has proven to be a veritable cliff-hanger for the world of biomedicine. At the same time that the US government stands poised on the brink of the so-called ‘fiscal cliff’, pharmaceutical companies are stumbling with the industry’s ‘patent cliff’ and academic researchers face the looming ‘funding cliff’. But not everything in 2012 was so dire, with dozens of new drugs to hit worldwide markets and countless discoveries made to enable the next generation of medicines. What follows are a set of ‘Cliff’s notes’ to the year that was for the field.  Read more

NIH working group changes tune, recommends more training grants

NIH working group changes tune, recommends more training grants

Graduate students and post-docs in the biomedical field compete for limited research money from the US National Institutes of Health (NIH) and, after spending years in training, face uncertain career paths. A working group charged with studying these problems presented a report to NIH Director Francis Collinsand his advisory committee yesterday— and offered some new solutions.  Read more